PURA VIDA INVESTMENTS, LLC - Q3 2017 holdings

Add to watchlist

$342 Million is the total value of PURA VIDA INVESTMENTS, LLC's 76 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 281.2% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$25,123,000–100,000
+100.0%
7.35%–
PFE NewPFIZER INCcall$17,850,000–500,000
+100.0%
5.22%–
LIVN BuyLIVANOVA PLC$10,808,000
+26.1%
154,273
+10.2%
3.16%
-7.1%
ICUI BuyICU MED INC$10,686,000
+37.7%
57,500
+27.8%
3.13%
+1.5%
MRK BuyMERCK & CO. INC$9,897,000
+18.8%
154,570
+18.9%
2.90%
-12.5%
XRAY NewDENTSPLY SIRONA INC$9,570,000–160,000
+100.0%
2.80%–
BAX NewBAXTER INTL INCput$8,471,000–135,000
+100.0%
2.48%–
BAX BuyBAXTER INTL INC$8,471,000
+11.9%
135,000
+8.0%
2.48%
-17.5%
XLV NewSELECT SECTOR SPDR TRput$8,173,000–100,000
+100.0%
2.39%–
CNC NewCENTENE CORP DEL$7,742,000–80,000
+100.0%
2.26%–
ATHN BuyATHENAHEALTH INC$7,437,000
+23.0%
59,800
+39.1%
2.18%
-9.3%
AGN NewALLERGAN PLC$7,173,000–35,000
+100.0%
2.10%–
BMY NewBRISTOL-MYERS SQUIBB COcall$6,374,000–100,000
+100.0%
1.86%–
XENT BuyINTERSECT ENT INC$6,230,000
+12.9%
200,000
+1.3%
1.82%
-16.8%
BIO BuyBIO RAD LABS INCcl a$6,222,000
+20.5%
28,000
+22.7%
1.82%
-11.2%
IWM NewISHARES TRput$5,927,000–40,000
+100.0%
1.73%–
DXCM NewDEXCOM INC$5,871,000–120,000
+100.0%
1.72%–
INCY NewINCYTE CORPput$5,837,000–50,000
+100.0%
1.71%–
INCY NewINCYTE CORP$5,837,000–50,000
+100.0%
1.71%–
WBA NewWALGREENS BOOTS ALLIANCE INCcall$5,405,000–70,000
+100.0%
1.58%–
PEN BuyPENUMBRA INC$5,380,000
+22.6%
59,579
+19.2%
1.57%
-9.6%
QDEL NewQUIDEL CORP$4,825,000–110,000
+100.0%
1.41%–
VRTX NewVERTEX PHARMACEUTICALS INC$4,546,000–29,900
+100.0%
1.33%–
AXGN BuyAXOGEN INC$4,437,000
+47.7%
229,278
+27.8%
1.30%
+8.8%
XBI NewSPDR SER TRput$4,329,000–50,000
+100.0%
1.27%–
ABT NewABBOTT LABS$4,269,000–80,000
+100.0%
1.25%–
ADMS NewADAMAS PHARMACEUTICALS INCcall$4,234,000–200,000
+100.0%
1.24%–
ABT NewABBOTT LABScall$4,002,000–75,000
+100.0%
1.17%–
EW BuyEDWARDS LIFESCIENCES CORPcall$3,826,000
+7.9%
35,000
+16.7%
1.12%
-20.5%
VRAY BuyVIEWRAY INC$3,497,000
+107.3%
607,040
+132.9%
1.02%
+52.7%
NewNABRIVA THERAPEUTICS PLC$3,481,000–425,000
+100.0%
1.02%–
FXH NewFIRST TR EXCHANGE TRADED FDput$3,371,000–50,000
+100.0%
0.99%–
ONCE NewSPARK THERAPEUTICS INC$3,351,000–37,589
+100.0%
0.98%–
IBB NewISHARES TRput$3,336,000–10,000
+100.0%
0.98%–
FPRX NewFIVE PRIME THERAPEUTICS INCcall$3,068,000–75,000
+100.0%
0.90%–
FOLD NewAMICUS THERAPEUTICS INCcall$3,016,000–200,000
+100.0%
0.88%–
PBYI NewPUMA BIOTECHNOLOGY INCcall$2,994,000–25,000
+100.0%
0.88%–
SIEN NewSIENTRA INC$2,892,000–187,800
+100.0%
0.85%–
BRKS NewBROOKS AUTOMATION INC NEW$2,884,000–95,000
+100.0%
0.84%–
ARNA BuyARENA PHARMACEUTICALS INC$2,848,000
+382.7%
111,700
+219.1%
0.83%
+256.0%
INSM NewINSMED INC$2,734,000–87,601
+100.0%
0.80%–
DXCM NewDEXCOM INCcall$2,691,000–55,000
+100.0%
0.79%–
QGEN NewQIAGEN NVcall$2,520,000–80,000
+100.0%
0.74%–
SRPT BuySAREPTA THERAPEUTICS INC$2,268,000
+124.3%
50,000
+66.7%
0.66%
+65.6%
ZGNX NewZOGENIX INCcall$2,194,000–62,600
+100.0%
0.64%–
PTCT NewPTC THERAPEUTICS INCcall$2,057,000–102,800
+100.0%
0.60%–
MOH NewMOLINA HEALTHCARE INC$1,719,000–25,000
+100.0%
0.50%–
AERI NewAERIE PHARMACEUTICALS INCput$1,711,000–35,200
+100.0%
0.50%–
NSTG NewNANOSTRING TECHNOLOGIES INCcall$1,616,000–100,000
+100.0%
0.47%–
NewSPECTRUM PHARMACEUTICALS INCnote 2.750%12/1$1,422,000–10,000
+100.0%
0.42%–
ZGNX NewZOGENIX INC$1,402,000–40,000
+100.0%
0.41%–
RVNC NewREVANCE THERAPEUTICS INC$1,378,000–50,000
+100.0%
0.40%–
DCPH NewDECIPHERA PHARMACEUTICALS IN$1,329,000–70,000
+100.0%
0.39%–
AGRX BuyAGILE THERAPEUTICS INC$1,291,000
+97.4%
289,501
+65.9%
0.38%
+45.4%
COLL NewCOLLEGIUM PHARMACEUTICAL INC$1,229,000–117,131
+100.0%
0.36%–
EXEL NewEXELIXIS INCcall$1,226,000–50,600
+100.0%
0.36%–
QDEL NewQUIDEL CORPput$1,228,000–28,000
+100.0%
0.36%–
RGNX BuyREGENXBIO INC$1,118,000
+96.5%
33,920
+17.7%
0.33%
+44.7%
NewINTEC PHARMA LTD JERUSALEM$895,000–100,000
+100.0%
0.26%–
BCRX BuyBIOCRYST PHARMACEUTICALS INC$786,000
+41.4%
150,000
+50.0%
0.23%
+4.1%
MEIP NewMEI PHARMA INCcall$527,000–196,500
+100.0%
0.15%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2021-02-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ICU MED INC26Q2 20234.2%
NANOSTRING TECHNOLOGIES INC26Q2 20233.3%
VIEWRAY INC25Q2 20233.2%
LIVANOVA PLC23Q3 20233.8%
ALEXION PHARMACEUTICALS INC23Q1 20214.3%
INSPIRE MED SYS INC22Q3 20233.7%
BOSTON SCIENTIFIC CORP22Q3 20224.8%
INVACARE CORP22Q3 20212.8%
ESTABLISHMENT LABS HLDGS INC21Q3 20235.0%
INTERSECT ENT INC21Q2 20212.6%

View PURA VIDA INVESTMENTS, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
PURA VIDA INVESTMENTS, LLC Q3 2017 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Stryve Foods Holdings, LLCApril 19, 20231,470,6495.6%
ICAD INCMarch 15, 20231,277,2145.0%
ESTABLISHMENT LABS HOLDINGS INC.February 14, 20231,002,7674.1%
Pulmonx CorpFebruary 14, 20231,216,2583.2%
Quotient LtdSold outFebruary 14, 202300.0%
Universe Pharmaceuticals INCSold outFebruary 14, 202300.0%
MedMen Enterprises, Inc.April 29, 2022139,755,07221.4%
INVACARE CORPSold outFebruary 14, 202200.0%
MedAvail Holdings, Inc.February 14, 2022714,1202.2%
TELA Bio, Inc.February 14, 2022564,1203.9%

View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2024-02-13

View PURA VIDA INVESTMENTS, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (341772000.0 != 341775000.0)
  • The reported has been restated
  • The reported has been amended

Export PURA VIDA INVESTMENTS, LLC's holdings

CSVXLS